J. Delattre

发表

Prediction of Response to Temozolomide in Low‐Grade Glioma Patients Based on Tumor Size Dynamics and Genetic Characteristics

F. Ducray, M. Lavielle, J. Honnorat, 2015, CPT: pharmacometrics & systems pharmacology.

Dementia Following Treatment of Brain Tumors with Radiotherapy Administered Alone or in Combination with Nitrosourea-based Chemotherapy: A Clinical and Pathological Study

C. Duyckaerts, J. Hauw, J. Delattre, 2004, Journal of Neuro-Oncology.

A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults: 4-year results.

J. Delattre, N. Sichez, M. Vigliani, 1996, International journal of radiation oncology, biology, physics.

The level of activity of the alternative lengthening of telomeres correlates with patient age in IDH-mutant ATRX-loss-of-expression anaplastic astrocytomas

F. Ducray, M. Sanson, O. Chinot, 2019, Acta Neuropathologica Communications.

Long-term impact of temozolomide on 1p/19q-codeleted low-grade glioma growth kinetics

F. Ducray, J. Honnorat, A. Idbaih, 2018, Journal of Neuro-Oncology.

Characteristics of IDH-mutant gliomas with non-canonical IDH mutation

F. Ducray, O. Chinot, B. Lhermitte, 2020, Journal of Neuro-Oncology.

Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies

J. Dalmau, J. Delattre, J. Dalmau, 2000, Neurology.

Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity

J-Y Delattre, Y. Marie, J. Honnorat, 2014, Oncogene.

[Gliomatous meningitis of hemispheric tumors. Study of 22 cases in adults].

C. Duyckaerts, G. Stragliotto, M. Poisson, 1995, Revue neurologique.

Pseudo-obstruction intestinale chronique et syndrome des anti-Hu : 13 ans de suivi sans apparition de néoplasie

A. Amiot, H. Sokol, B. Messing, 2008 .

Clinical outcome of patients with anti-Hu–associated encephalomyelitis after treatment of the tumor

J. Molinuevo, J. Delattre, P. Broët, 1999, Neurology.

Treatment of malignant recurrent glioma by infra-arterial, infra-ophtalmic infusion of HECNU 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl) urea

J. Chiras, M. Poisson, J. Delattre, 1990, Journal of Neuro-Oncology.

Intra arterial chemotherapy with ACNU and radiotherapy in inoperable malignant gliomas

L. Capelle, P. Cornu, J. Chiras, 1996, Journal of Neuro-Oncology.

Treatment of recurrent malignant supratentorial gliomas with the association of carboplatin and etoposide: a phase II study

L. Chauveinc, M. Poisson, A. Ameri, 1997, Journal of Neuro-Oncology.

Treatment of malignant gliomas with surgery, intra-arterial infusions of 1-(2-hydroxyethyl)chloroethylnitrosourea, and radiation therapy: a phase II study.

G. Chatellier, J. Chiras, D. Fohanno, 1990, Neurosurgery.

Treatment of Meningeal Gliomatosis

K. Hoang-Xuan, P. Cornu, N. Martin-Duverneuil, 1999, Journal of Neuro-Oncology.

Treatment of recurrent malignant supratentorial gliomas with carboplatin (CBDCA)

J. Chiras, Y. Péréon, M. Poisson, 1991, Journal of Neuro-Oncology.

J. Honnorat, B. Giometto, A. Vincent, 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[Late cerebral complications of radiotherapy].

M. Poisson, J. Delattre, L. Albuquerque, 1994, Annales de medecine interne.

[Radiation-induced neuropathies. Experimental and clinical data].

P. Pradat, M. Poisson, J. Delattre, 1994, Revue neurologique.

Treatment of syndromes with antineuronal antibodies (Anti-Hu, Anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone

F. Keime-Guibert, J. Delattre, F. Graus, 2000 .

Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies

J. Delattre, F. Graus, I. Bonaventura, 1992, Neurology.

P18 tumor suppressor gene and progression of oligodendrogliomas to anaplasia

K. Hoang-Xuan, Y. Marie, M. Sanson, 2000, Neurology.

Palatal myoclonus and inferior olivary lesions: MRI-pathologic correlation.

C. Duyckaerts, P. Cervera-Pierot, L. Pierot, 1992, Journal of computer assisted tomography.

Treatment of recurrent malignant supratentorial gliomas with the association of procarbazine, thiotepa and vincristine: A phase II study

M. Poisson, J. Delattre, A. Améri, 1993, Journal of Neuro-Oncology.

A phase I study of an anti-epidermal growth factor receptor monoclonal antibody for the treatment of malignant gliomas.

H. Magdelenat, T. Faillot, D. Fohanno, 1996, Neurosurgery.

[Metastasis to the pituitary stalk in a case of breast cancer].

M. Poisson, C. Castelain, J. Delattre, 1990, Revue neurologique.

[Necrosis of the optic tract, hypothalamus and brain stem after irradiation of a pituitary adenoma with conventional doses].

C. Duyckaerts, J. Hauw, J. Delattre, 1986, Revue neurologique (Paris).

Comparison study of CT and positron emission tomographic data in recent cerebral infarction.

D Comar, J Bories, J. Baron, 1983, AJNR. American journal of neuroradiology.

Systemic lupus erythematosus with anti-Hu antibodies and polyradiculoneuropathy

Z. Amoura, A. Carpentier, J. Delattre, 2001, Neurology.

Complete bilateral horizontal gaze paralysis disclosing multiple sclerosis

D. Milea, P. le Hoang, J. Delattre, 2001, Journal of neurology, neurosurgery, and psychiatry.

Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas

X. Estivill, K. Hoang-Xuan, G. Thomas, 1995, Genes, chromosomes & cancer.

tomographic data in recent cerebral infarction. Comparison study of CT and positron emission

J. Chiras, D. Comar, M. Bousser, 2013 .

Leptomeningeal gliomatosis with spinal cord or cauda equina compression: a complication of supratentorial gliomas in adults

M. Rosenblum, J. Delattre, R. Walker, 1989, Acta neurologica Scandinavica.

Diffuse primary leptomeningeal gliomatosis

C. Duyckaerts, M. Poisson, J. Delattre, 2005, Journal of Neuro-Oncology.

Long-term impact of temozolomide on 1p/19q-codeleted low-grade glioma growth kinetics

F. Ducray, J. Honnorat, A. Idbaih, 2018, Journal of Neuro-Oncology.